Samil PharmaceuticalLtd Bilan de santé
Santé financière contrôle des critères 1/6
Samil PharmaceuticalLtd has a total shareholder equity of ₩174.4B and total debt of ₩140.5B, which brings its debt-to-equity ratio to 80.6%. Its total assets and total liabilities are ₩379.5B and ₩205.1B respectively. Samil PharmaceuticalLtd's EBIT is ₩6.3B making its interest coverage ratio 2.4. It has cash and short-term investments of ₩2.0B.
Informations clés
80.6%
Ratio d'endettement
₩140.53b
Dette
| Ratio de couverture des intérêts | 2.4x |
| Argent liquide | ₩2.01b |
| Fonds propres | ₩174.36b |
| Total du passif | ₩205.10b |
| Total des actifs | ₩379.46b |
Mises à jour récentes de la santé financière
We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt
Sep 11
Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?
May 24Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden
Apr 01Recent updates
Optimistic Investors Push Samil Pharmaceutical Co.,Ltd (KRX:000520) Shares Up 29% But Growth Is Lacking
Sep 13We Think Samil PharmaceuticalLtd (KRX:000520) Is Taking Some Risk With Its Debt
Sep 11Investor Optimism Abounds Samil Pharmaceutical Co.,Ltd (KRX:000520) But Growth Is Lacking
Jul 29Does Samil PharmaceuticalLtd (KRX:000520) Have A Healthy Balance Sheet?
May 24There's Reason For Concern Over Samil Pharmaceutical Co.,Ltd's (KRX:000520) Massive 29% Price Jump
Mar 30Samil PharmaceuticalLtd's (KRX:000520) Earnings Are Of Questionable Quality
Mar 21Here's Why Samil PharmaceuticalLtd (KRX:000520) Has A Meaningful Debt Burden
Apr 01Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment
Mar 11Are Dividend Investors Getting More Than They Bargained For With Samil Pharmaceutical Co.,Ltd's (KRX:000520) Dividend?
Feb 15
Should You Be Concerned About Samil Pharmaceutical Co.,Ltd's (KRX:000520) ROE?
Jan 20Why It Might Not Make Sense To Buy Samil Pharmaceutical Co.,Ltd (KRX:000520) For Its Upcoming Dividend
Dec 24Samil PharmaceuticalLtd (KRX:000520) Has Gifted Shareholders With A Fantastic 221% Total Return On Their Investment
Dec 09What Is The Ownership Structure Like For Samil Pharmaceutical Co.,Ltd (KRX:000520)?
Nov 18Analyse de la situation financière
Passif à court terme: A000520's short term assets (₩84.7B) do not cover its short term liabilities (₩114.3B).
Passif à long terme: A000520's short term assets (₩84.7B) do not cover its long term liabilities (₩90.8B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: A000520's net debt to equity ratio (79.4%) is considered high.
Réduire la dette: A000520's debt to equity ratio has reduced from 112.5% to 80.6% over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: A000520 has less than a year of cash runway based on its current free cash flow.
Prévisions de trésorerie: A000520 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.4% each year